| |||
| Names | |||
|---|---|---|---|
| IUPAC names α-naloxol: (4R,4aS,7S,7aR,12bS)-3-allyl-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol β-naloxol: (4R,4aS,7R,7aR,12bS)-3-allyl-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol | |||
| Identifiers | |||
| |||
3D model (JSmol) |
| ||
| ChemSpider | |||
| ECHA InfoCard | 100.236.696 | ||
| UNII |
| ||
| |||
| |||
| Properties | |||
| C19H23NO4 | |||
| Molar mass | 329.396 g·mol−1 | ||
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |||
Naloxol is anopioid antagonist closely related tonaloxone. It exists in twoisomeric forms, α-naloxol and β-naloxol.
α-naloxol is a humanmetabolite of naloxone.[1] Synthetically, α-naloxol can be prepared from naloxone byreduction of theketone group, and β-naloxol can be prepared from α-naloxol by aMitsunobu reaction.[2]
Naloxol can be said to be theoxymorphol analogue of naloxone.